DOT1L is involved in tumorigenesis and tumor metabolism or metastasis of ovarian cancer (37, 38), prostate cancer (39, 40), leukemia (41, 42), neuroblastoma (43), colorectal cancer (44), and breast cancer (45). This evidence concerns the gene DOT1L and ovarian carcinoma.